In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Bid For Genentech, How High Can Roche Go?

Executive Summary

Roche's effort to clinch a buy-out of Genentech has moved to a new, critical stage of negotiations. But just how much can Roche afford to pay for the top-of-the-line biotech, which comes with A-list scientific talent, an extensive pipeline heavily weighted in the lucrative arena of oncology, and a price tag to match?
Advertisement

Related Content

Roche/Genentech: A Case Study For Future Hostile Offers
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2008
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2008
Credit Woes Hit Pharma
Credit Woes Hit Pharma
ImClone and Bristol: The Acquisition Fight Focuses on the Erbitux Successor
Roche's Acquisition of Genentech: Retention Program Unlikely to Stem Departures
ImClone and Bristol: The Acquisition Fight Focuses on the Erbitux Successor
After Roche/Genentech: Pharma's Focus on Efficiencies, Not Innovation
After Roche/Genentech: Pharma's Focus on Efficiencies, Not Innovation

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003169

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel